SCHEMBL2738773

SCHEMBL2738773

NC(=O)[C@H](CN1CCC(O)CC1)c1ccc(I)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA3 P22001 1/20 0.38
▸ MITF O75030 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ PAX8 Q06710 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HTR2A P28223 3/20 0.36
▸ ACACB O00763 1/20 0.35
▸ OPRM1 P35372 1/20 0.34
▸ OPRD1 P41143 1/20 0.34
▸ OPRK1 P41145 1/20 0.34
▸ SIGMAR1 Q99720 3/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2738529 0.86 SLC18A3 (0.44) KCNA3MITFALDH1A1HTTRAB9A
SCHEMBL12028792 0.86 NTSR1 (0.45) ALDH1A1SIGMAR1CYP3A4TSHR
SCHEMBL8217369 0.86 NTSR1 (0.45) ALDH1A1SIGMAR1CYP3A4TSHR
SCHEMBL12323877 0.86 PAX8 (0.39) KCNA3MITFALDH1A1HTTRAB9A
SCHEMBL12323915 0.84 ACACB (0.39) KCNA3MITFALDH1A1HTTRAB9A
SCHEMBL12292976 0.82 HTR2A (0.35) KCNA3HTR2AOPRM1OPRK1CYP2D6
SCHEMBL8225848 0.82 TACR2 (0.38) KCNA3ALDH1A1OPRK1CYP2D6HTR7
SCHEMBL12028860 0.81 ALDH1A1 (0.42) MITFALDH1A1HTTRAB9AGFER
SCHEMBL2738777 0.80 TACR2 (0.47) ALDH1A1OPRK1CYP2D6HTR7
SCHEMBL2738488 0.78 OPRK1 (0.43) OPRM1OPRD1OPRK1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2402325-A2 Hydroxylated and methoxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors Array Biopharma, Inc. (US) 2012-01-04 — — EP disclosed
Send feedback